DJIA 17,619.51 23.16 0.13%
NASDAQ 4,986.87 0.00 0.00%
S&P 500 2,063.11 5.47 0.27%
market minute promo

Gilead Sciences (NASDAQ: GILD)

117.08 1.63 (1.41%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GILD $117.08 1.41%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $117.29
Previous Close $115.46
Daily Range $116.78 - $118.30
52-Week Range $82.63 - $123.37
Market Cap $172.1B
P/E Ratio 13.15
Dividend (Yield) $1.72 (1.5%)
Ex-Dividend Date
Dividend Pay Date
06/12/15
06/29/15
Volume 11,339,729
Average Daily Volume 10,768,749
Current FY EPS $11.04

Sector

Healthcare

Industry

Drug Makers

Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website: http://www.gilead.com/

News & Commentary Rss Feed

The Overlooked Reason Why I Think Gilead Sciences Stock Remains Undervalued

Even after an incredible multi-year run, I think Gilead Sciences still has a lot of room to run. And surprisingly, it's got nothing to do with the P/E ratio.

Premarket Biotech Digest: Geron's Sharp Gain, Bayer Essure AEs, Juno Moves Higher

Fast Money Picks For July 1

Jim Cramer's Top Takeaways: Celgene, Gilead Sciences, Regeneron, Alarm.com, TransUnion

'Fast Money' Recap: Greece's Uncertain Future Extends to U.S. Stocks

Julian Robertson Discusses Greece Threat, Stocks and Apple

Celldex's Rintega Phase III Study Recommended to Continue - Analyst Blog

Celldex's Rintega Phase III Study Recommended to Continue - Analyst Blog

Sarepta Files Eteplirsen NDA, Secures $40M Debt Financing - Analyst Blog

3 Drugs Stocks Driving The Industry Higher

Biotech Investors Should Read Bibliographies Of Chief Scientific Officers

See More GILD News...

GILD's Top Competitors

GILD $117.08 (1.41%)
Current stock: GILD
AMGN $153.52 (1.27%)
Current stock: AMGN
CELG $115.74 (0.72%)
Current stock: CELG
$0.00 (0.00%)
Current stock: